chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After receiving Men B she states arm was immediately sore at site of the injection, also for the first couple of days and then for the first week after the injection. She now complains of Sharp pain of upper mid arm when she lifts something heavy or extends arm. She states is a non-consistent sharp pain. States when she changes position pain goes away. Referred to Primary Care Provider for evaluation of symptoms.
24 hours after shots, arm red, swollen rash around injection site. BENADRYL given per manufacturer directions.
Information has been received from a registered nurse concerning a 20 week old infant who was vaccinated on 07-DEC-2007 with an oral dose of Rotateq. No problems were reported. It was not reported if medical attention was sought. There was no product quality complaint involved. Additional information is not expected.
Pt. has redness, soreness, swelling and itching at site of injection. Symptoms began w/i 24 hrs of receiving vaccine. Pt stated she will take BENADRYL.
w/in 20 mins pt exp erythema, swelling (sl) & numbness @ inject site & faint erythema entire arm;
Case was vaccinated and boosted for Covid, yet was hospitalized for and died of Covid 3 months later.  Hospitalized at:  Hospital.  Case was admitted to hospital following several falls, increased aggitation, weakness and confusion. While case tested positive for Covid, she had no respiratory symptoms, yet medical notes indicate other symptoms were likely attributable to Covid infection. Case remained hospitalized until she passed away.
Arm pain; Stomach pain; I feel like vomiting; I feel like throwing up; This is a spontaneous report from a contactable consumer (patient father).   A 13-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0191, Expiration Date: 13Jun2021), via an unspecified route of administration, administered in left hand on 13Jun2021 as 1st dose, single dose for covid-19 immunisation. Medical history included was none and there were no concomitant medications. On 14Jun2021, Reporter stated that My daughter, she got the Pfizer COVID vaccine. She has the problem. The arm pain, which was normal because she passed all dosage stage however she keeps complaining about the stomach pain and then she says I feel like throwing up and which was, vaccination was happen on Sunday but she was keeps complaining like on 14Jun2021 Monday night, 15 Jun2021Tuesday night and also 16Jun2021 night and I thought let me update you. Is it normal or something different? She has not thrown up yet but she feel like throwing up and she was having pain in her stomach. She said, I feel like vomiting but no vomit so far but stomach pain still going on. Reporter stated that, I would like to know was that normal or she should checked by the doctor or she should  wait one or two days more to get better or any other side effects which needs to be check right away. I mean she do not have any like fever or feel like emergency or anything. She was waking up in night two times. The outcome of the event arm pain and felt like vomiting was unknown and not recovered for other events.  Information on lot/batch number was available. Additional information has been requested.
Onset of symptoms began approximately 14 hours after receiving the vaccine and improved within 24 hours, although some are lingering at the time of this report.  Patient experienced fever, severe headache, joint pain, injection site pain, weakness and fatigue.  Patient took Tylenol and took a sick day to rest.
His wife ended up contracting Alpha-Gal by Ticks; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect via contactable consumers (patient's husband, and patient herself). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient ended up contracting alpha-gal by ticks on an unspecified date. The reporter asked about the ingredients of the COVID-19 vaccine, if it contains mammalian cells, dairy, guinea pig 1 cell, or cholesterol origin. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Information has been received from a pharmacist referring to a patient of unknown age and gender. Concurrent conditions and medical history of the patient were not reported. On 06-DEC-2015 the patient was vaccinated with a dose of ZOSTAVAX (lot # L026415, expiry date 15-OCT-2015) (dose and route unspecified), that was reconstituted 30 hours before on 05-DEC-2015. No adverse effect reported. Additional information has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old male patient received BNT162b2 (BNT162B2), on 03Apr2021 as dose 1, single (Batch/Lot number: unknown), on 30Apr2021 as dose 2, single (Batch/Lot number: unknown) and on 16Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: Other medical history: High blood pressure. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical information: Age group was adult (18-64 Years). No other medication were received in 2 weeks. The anti viral product were COVID 19 treatment and brand-Paxlovid on 26May2022 to 30May2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recv vax 2AUG95 & 20NOV96 pt devel a chickenpox-like rash consisting of about 2 dozens;
1 of 2 pts vax from the same vial who exp a red, hot, tender, swollen arm w/in 18-24 hrs following vax lasting 3-4 days; no treatement initiated; no cultures taken & no drainage; pt recovered;
This case was reported by a nurse via call center representative and described the occurrence of injection site erythema in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema was recovered/resolved. It was unknown if the reporter considered the injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that a patient experienced an area of redness around the injection site which lasted for three weeks. The patient visited their doctor. The reporter did not have additional information.
After retrieveing needle some of the vaccine drip down the arm. Patient reported leakage at the observation area. Recipient vaccinated in opposite arm by another nurse.
injection site area became red; injection site area became swollen; injection site area became itchy; injection site area became hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site area became red), VACCINATION SITE SWELLING (injection site area became swollen), VACCINATION SITE PRURITUS (injection site area became itchy) and VACCINATION SITE WARMTH (injection site area became hot) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no adverse events were reported).    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site area became red), VACCINATION SITE SWELLING (injection site area became swollen), VACCINATION SITE PRURITUS (injection site area became itchy) and VACCINATION SITE WARMTH (injection site area became hot). At the time of the report, VACCINATION SITE ERYTHEMA (injection site area became red), VACCINATION SITE SWELLING (injection site area became swollen), VACCINATION SITE PRURITUS (injection site area became itchy) and VACCINATION SITE WARMTH (injection site area became hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Over a week, range of motion, throbbing pain relieved by ADVIL. No redness. Shoulder to wrist still experiencing pain 10/20/14.
redness,  swelling, itchiness, and rash spreading to the chest,  back, and face. Also complained of an itchy throat.
Child received an immunocompromised dose outside of original series and should have received a Pfizer bivalent. Primary series Pfizer.
16SEP91 pt had screaming 6-8 hrs p/DTP/HIB w/swelling & redness of lt MLT-(DTP site) seen by MD 19SEP91;
CHILLS, VOMIT & BOTH ARMS SPASTIC FOR ABOUT 20 MINS.
Within 48 hours post vax, the pt began to lose eye contact with parents, and also lost the 6-10 words he had begun to say. Regression followed. He was dx with metabolic disorder, autism spectrum disorder, and apraxia of speech.
This spontaneous report as received from a healthcare student refers to a female patient of unknown age, who on 31-JUL-2012, was vaccinated with GARDASIL first dose (route and lot # not reported) and on 17-JAN-2013, was vaccinated with a second dose of GARDASIL (route and lot # not reported). No adverse symptoms reported. Additional information has been requested.
Menveo administered in right deltoid at 1129. Boostrix administered in left deltoid at 1130. Patient immediately had vasovagal syncopal episode at 1130. Pulse +3.  Patient regained consciousness at 1131. Patient AOx4. 8 oz of water given to patient. Granola bar given to patient. Vitals 1137: O/2 98%, P 82, B/P 96/60 right brachial, RR 18. Patient care transferred to school nurse.  Follow-up call made @ 1030 05-26-2023 to patient mother. No complications noted.
I took an administered COVID-19 on 10/29/2022 for a cruise I was going on. That came back negative. I then tested positive for COVID-19 on 11/01/2022. It started with a very runny nose and some sneezing and a little chest congestion on 10/31/2022. Then what I was most troubled by was a very sore throat in the morning and that lasted for about 3 days. I simply treated it with throat lozenges. Luckily the symptoms were mild. After 5 days, I was fine.
Baseline temperature before injection was 97.5 degreees. Temperature spiked up to 102 degrees by 9:45pm and intense chills. Extremeties extremely cold.  Intense headache began at same time and became almost intolerable by midnight with the feeling of stabbing behind the eyes. Nausea began the next morning and fever/chills continued throughout following day.
I am a healthy female who would work out 2-3 days a week.  I developed redness and swelling at injection site both times that lasted 3-4 days.  Then on October 3rd, I developed chest pain.  Went to ER and was diagnosed with pericarditis and pericardial effusion.  Moderate to large amount of fluid around heart.  At present time, I still have pericarditis and pericardial effusion.  I have been taking medication since Oct. 2021 with no changes in the amount of fluid.  I then was ill with COVID on 12/31 21.
FLUARIX given in left deltoid per RN at 3:50 P.M. At 3:55 PM patient c/o itching at injection site with whelping rash noted below shoulder. Cold compress applied. Patient employee.
Pt states Friday evening she began to feel nauseous. She has diarrhea and the (L) arm was red and swollen. Pt reports she could feel a knot at injection site. Seen in clinic on 7-2-18, CXR and CBC ordered. Rest.
Pt started with erythema and itching around site of injection of vaccine about 1 week ago. Presented to our clinic today. Also has couple of red lesions on chest and one on arm. Lesion are non-vesicular. Pt has also posterior lymphadenopathy.
Positive COVID test on 07Jan2022; Positive COVID test on 07Jan2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 10 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date Nov2021 (Batch/Lot number: unknown) at the age of 10 years as dose 2, single and administration date Nov2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant) with onset 07Jan2022, outcome "recovering" and all described as "Positive COVID test on 07Jan2022". The event "positive covid test on 07jan2022" was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 antibody test: (04Jan2022) negative, notes: Nasal Swab; (05Jan2022) negative, notes: Nasal Swab; (07Jan2022) positive, notes: Nasal Swab; sars-cov-2 test: (05Jan2022) positive, notes: Nasal Swab. Therapeutic measures were taken as a result of covid-19.  Additional information: The patient did not receive any other vaccine within four weeks prior to COVID vaccine. Prior to vaccination the patient was not diagnosed to COVID-19. The patient did not had any known allergies. The patient was treated with ibuprofen for adverse events.  The lot number for bnt162b2 was not provided and will be requested during follow up.
1:50am woke up with aches all over body, skin hurt, teeth hurt, fever, headache. Mid afternoon the stabbing chest pain that I could feel in my upper middle back started. Had last chest pain around 11pm, went to bed. Woke up with just a headache the next morning.
Welts in addition to redness and swelling measuring 2 1/2 inches by  1 1/2 inches. around injection site.
This spontaneous report as received from a Registered Nurse refers to multiple unspecified patients of unknown ages and gender. On an unspecified date the multiple unspecified patients were administered VAQTA (Lot# unspecified) (dose, frequency, route and location unspecified) that was stored improperly (first exposed to 9C for 30 minutes and then exposed to 8.3C for 1 hour). No adverse effects were reported. Follow up information has been received from the registered nurse via telephone call indicating that she did not have the information available at that time and she might be able to fax it early the following week. This is one of several reports received from the same source. Follow up has been received from the registered nurse. The nurse provided lot numbers, expiration dates and a list of patient identifier representing patients given affected vaccine from 16-APR-2014 through 23-APR-2014. On unspecified dates in April 2014, 11 (eleven) patients were given affected VAQTA (lot # J011629, expiration dates: 20-SEP-2015). The 11 patients included: MARRS# 1404USA014966, MARRS# 1405USA013228, MARRS# 1405USA013233, MARRS# 1405USA013234, MARRS# 1405USA013235, MARRS# 1405USA013236, MARRS# 1405USA013232, MARRS# 1405USA013231, MARRS# 1405USA013237, MARRS# 1405USA013229, MARRS# 1405USA013230. Additional information is not expected.
appetite change, chills, fatigue, fever, congestion, postnasal drip, sore throat, cough, SOB, chest pain, myalgias
My left hand became sore and swollen Monday evening. I have no recollection of jamming my middle finger or doing anything different with my hand that day. When I woke up Tuesday, I could barely open my hand as the tendon was extremely tight and sore. The finger was swollen, and my grip strength was significantly diminished. The pain and swelling decreased to almost normal by Friday, but on Saturday I adjusted my clothes as usual and felt a pop. The only change from normal was getting the vaccine.
Red and itching rashes appeared a few days after the initial shot, at which time I tested positive for Covid-19. The rashes seemed localized to my legs and feet and then progressed to my arms, face, and neck for about 3 months. After Holiday the rash spread across my back and began to stay longer each time. I applied Eucerin cream to the affected areas with some degree of relief. I finally decided to admit myself to the ER on 2/11/2022 for a more direct approach to treatment. I was prescribed Prednizone and Hydroxizine. After sending the pictures of my affliction to 2 nurse practitioners I was told what I may be experiencing is a cytokine storm. I'm certain i am not allergice to anything in my environment, because nothing new was introduced into the environment and I've never experienced anything like the remaining prickle points and raised skin left behind for hours after an attack.
There is a feeling of a hot, heat and cold/I am standing in the sun and just one side of my body is heated; There is a feeling of a hot, heat and cold; Unilateral searches on my right side of my body; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old patient received bnt162b2 (BNT162B2), administration date May2021 (Lot number: ER8731, Expiration Date: 31Jul2021) at the age of 37 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: FEELING HOT (non-serious) with onset 01May2021, outcome "not recovered", described as "There is a feeling of a hot, heat and cold/I am standing in the sun and just one side of my body is heated"; FEELING COLD (non-serious) with onset 01May2021, outcome "not recovered", described as "There is a feeling of a hot, heat and cold"; FEELING ABNORMAL (non-serious) with onset 01May2021, outcome "not recovered", described as "Unilateral searches on my right side of my body". Therapeutic measures were not taken as a result of feeling hot, feeling cold, feeling abnormal.  Additional information: Consumer Stated, So I am just calling to report and have to ask about a symptom that I experienced from my Covid vaccine that I received in Thursday just last week Thursday. The symptom that I am experiencing is a unilateral searches on my right side of my body. I am feeling like there is a feeling of a hot, heat and cold. So it's like I am standing in the sun and just one side of my body is heated up by the sun that kind of thing but I don't experience a fever.  No follow-up attempts are possible. No further information is expected.
Extreme fatigue; Full body sweats; Headache; Injection site pain; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 07Apr2021 at 11:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. Concomitant medications were not reported. Allergies to medications, food or other products were reported as unknown. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Mar2021 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 12:00, the patient experienced extreme fatigue, full body sweats, headache and injection site pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events extreme fatigue, full body sweats, headache and injection site pain was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Dry mouth, mouth sores, redness & swelling to skin around mouth/lips area.
Information has been received from a 16 year old white female consumer who was vaccinated with a 1st and 2nd dose of Varicella virus vaccine live SC in the left arm on 03/10/00 and 04/07/00, respectively. On 04/10/00,the patient was "broken out with spots, and diagnosed with chickenpox. On 04/11/00, the patient was seen by a physician again and re-diagnosed with an allergic reaction to the vaccine. The patient's pox looked more like welts, there were swollen red areas on her hips, knees, feet, hands, and arms. It was very painful for her to walk, and her head itched. The patient was very uncomfortable until 04/13/00 evening and on the morning of 04/14/00, she was 99% better." Follow-up information from a physician indicated that on 04/10/00, the patient developed a rash described as "red, papular, few with central vesicle on the chest, back, lower extremity, some hive-like." At the same time of the 2nd dose of Varicella virus vaccine live, the patient had been treating a wart on her left thumb and subsequently developed cellulitis. The patient did not have a fever. The patient was diagnosed with "atypical varicella vs. allergic reaction" and was given ceftriaxone sodium (Rocephin) and diphenhydramine HCL (Benadryl) PO. The patient was seen by a physician again on 04/11/00 complaining of pain with movement. The patient's cellulitis was "better; the other rash was more flat on left extremity, feet, and back." The patient was given amoxicillin trihydrate (+) clavulanate potassium (Augmentin) and loratadine (Claritin). On 04/13/00, a telephone follow-up indicted that the rash was gone but the patient's feet were still painful. On 04/18/00, the patient had recovered. The patient's experience was considered to be other medical events.
Lymphadenopathy left  axilla and sub clavicular since 2/26.
Day 1, loose stools that night. Day 2, loose stools and a sore throat. Day 3, sore throat and runny nose. Day 4, nose runny like a faucet and cough. Day 5, runny nose, sore throat, coughing a lot. Took some Theraflu. Day 6, no more sore throat but coughing and some shortness of breath on exertion and at rest. Day 7, coughing, nose not running as much, shortness of breath still present. Day 8, shortness of breath, coughing a lot. Day 9 (Tuesday, January 19, 2021) still coughing and experiencing Shortness of breath. Texted my manager and explained whatvhad been going on since I got the second vaccine and that I wasn't sick prior to getting it. And that no other family member in my home was sick besides me. She put me in touch with the HR director who scheduled n e for a COVID test that same night. I went to have the test done and also had the ER doctor to evaluate me because I was feeling so bad with the coughing and Shortness of breath. Today, I am still coughing, producing nasal drainage, and feeling short of breath at times.